Physician profile
Killol K Patel
NPI 1467743286
$15,100.84
in general payments reported to CMS, 2019-2025
54 companies · $1,927 in 2025
The $1,927 reported for 2025 was more than what 75% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,639 · 2020: $1,033 · 2021: $2,435 · 2022: $1,309 · 2023: $2,182 · 2024: $2,578 · 2025: $1,927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,180 · Travel and Lodging: $1,002 · Education: $304 · Consulting Fee: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,179.88 |
| Travel and Lodging | $1,002.34 |
| Education | $303.62 |
| Consulting Fee | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pulmonx Corporation | $2,437.01 | 2019-2025 | Chartis Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Covidien LP | $1,961.49 | 2019 | |
| Ethicon INC. | $1,622.61 | 2019-2022 | |
| Glaxosmithkline, LLC. | $1,560.60 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $1,001.44 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $541.42 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Steris Corporation | $541.35 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $524.10 | 2019-2025 | Uptravi, Opsumit |
| Genzyme Corporation | $472.45 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $459.83 | 2019-2024 | |
| Intuitive Surgical, INC. | $319.87 | 2019-2025 | |
| Boston Scientific Corporation | $292.38 | 2021-2024 | Acquire |
| Regeneron Healthcare Solutions, INC. | $291.25 | 2019-2024 | Dupixent |
| Galvanize Therapeutics, INC | $258.50 | 2024 | Aliya System |
| Noah Medical Corporation | $245.14 | 2024 | Galaxy |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $245.01 | 2019-2025 | Tyvaso, Orenitram, Remodulin |
| Pinnacle Biologics, INC | $230.71 | 2024-2025 | Photofrin |
| Mylan Specialty L.P. | $218.23 | 2019-2024 | Yupelri |
| Advanced Respiratory, INC | $209.43 | 2019-2021 | |
| Grifols USA, LLC | $180.67 | 2019-2025 | Prolastin-C Liquid |
| Inspire Medical Systems, INC. | $172.83 | 2023-2024 | Inspire |
| Davol INC. | $162.27 | 2025 | Phasix Mesh |
| Amgen INC. | $146.72 | 2022-2025 | Tezspire |
| Harmony Biosciences LLC | $89.48 | 2022-2023 | Wakix |
| Abbvie INC. | $69.99 | 2021-2024 | |
| Mallinckrodt Hospital Products INC. | $60.49 | 2021-2025 | Acthar |
| Verona Pharma, INC. | $52.45 | 2025 | Ohtuvayre |
| Alexion Pharmaceuticals, INC. | $48.17 | 2022-2023 | Ultomiris |
| Ethicon US, LLC | $46.41 | 2023-2024 | Linx Reflux Management System, Enseal |
| Philips North America LLC | $46.17 | 2022-2023 | |
| Insmed, INC. | $45.29 | 2024-2025 | Arikayce |
| Jazz Pharmaceuticals INC. | $42.28 | 2019-2020 | |
| Horizon Therapeutics Plc | $39.77 | 2019-2021 | |
| Gilead Sciences, INC. | $37.96 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $36.95 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $32.53 | 2025 | Lumryz |
| Solventum Corporation | $32.01 | 2024-2025 | V.A.C.Ulta, Prevena, V.A.C. Veraflo |
| Baxter Healthcare | $29.71 | 2022 | |
| Kerecis Limited | $28.55 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Csl Behring | $26.53 | 2020-2022 | |
| Mallinckrodt Enterprises LLC | $26.29 | 2019 | |
| Nabriva Therapeutics, Plc | $23.22 | 2020 | |
| Becton, Dickinson and Company | $22.91 | 2024 | Phasix Mesh |
| Lilly USA, LLC | $18.50 | 2025 | Zepbound |
| La Jolla Pharmaceutical Company | $17.48 | 2019 | |
| Novo Nordisk INC | $16.41 | 2021 | |
| Pharming Healthcare, INC. | $16.01 | 2023 | Ruconest |
| Pacira Pharmaceuticals Incorporated | $15.63 | 2024 | Exparel, Iovera |
| Integra Lifesciences Corporation | $15.29 | 2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Ucb, INC. | $15.00 | 2020 | |
| Genentech USA, INC. | $14.00 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.93 | 2021 | |
| Siemens Medical Solutions USA, INC. | $13.45 | 2024 | Cios Spin |
| Itamar Medical INC | $12.67 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Killol Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.